Emelie Englund
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emelie Englund has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Carmen Rodriguez-Cupello
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
2 shared publications - Chris Denis Madsen
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
2 shared publications - Christelle N. Prinz
Department of Physics, Division of Solid State Physics, Lund University, Lund, Sweden, Sweden
2 shared publications David Lindgren
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
2 shared publications- Håkan Axelson
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
2 shared publications - Johannes Kumra Ahnlide
Lund University 5 Department of Clinical Sciences Lund, Division of Infection Medicine, Faculty of Medicine SE-221 84 Lund
2 shared publications
Latest Publications
- RetractionOpen Access
- 23 September 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (10) , 1817
Retraction Note: CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling
- 23 September 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (10) , 1817
RetractionOpen AccessRetraction Note: CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling
- Retracted
- 5 July 2021
- Published by Springer Nature in Nature Cell Biology
- Vol. 23 (7) , 758-770
RETRACTED ARTICLE: CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling
The YAP/TAZ transcriptional programme is not only a well-established driver of cancer progression and metastasis but also an important stimulator of tissue regeneration. Here we identified Cerebral cavernous malformations 3 (CCM3) as a regulator of mechanical cue-driven YAP/TAZ signalling, controlling both tumour progression and stem cell differentiation. We demonstrate that CCM3 localizes to focal adhesion sites in cancer-associated fibroblasts, where it regulates mechanotransduction and YAP/TAZ activation. Mechanistically, CCM3 and focal adhesion kinase (FAK) mutually compete for binding to paxillin to fine-tune FAK/Src/paxillin-driven mechanotransduction and YAP/TAZ activation. In mouse models of breast cancer, specific loss of CCM3 in cancer-associated fibroblasts leads to exacerbated tissue remodelling and force transmission to the matrix, resulting in reciprocal YAP/TAZ activation in the neighbouring tumour cells and dissemination of metastasis to distant organs. Similarly, CCM3 regulates the differentiation of mesenchymal stromal/stem cells. In conclusion, CCM3 is a gatekeeper in focal adhesions that controls mechanotransduction and YAP/TAZ signalling.
- 5 July 2021
- Published by Springer Nature in Nature Cell Biology
- Vol. 23 (7) , 758-770
RetractedRETRACTED ARTICLE: CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling
The YAP/TAZ transcriptional programme is not only a well-established driver of cancer progression and metastasis but also an important stimulator of tissue regeneration. Here we identified Cerebral cavernous malformations 3 (CCM3) as a regulator of mechanical cue-driven YAP/TAZ signalling, controlling both tumour progression and stem cell differentiation. We demonstrate that CCM3 localizes to focal adhesion sites in cancer-associated fibroblasts, where it regulates mechanotransduction and YAP/TAZ activation. Mechanistically, CCM3 and focal adhesion kinase (FAK) mutually compete for binding to paxillin to fine-tune FAK/Src/paxillin-driven mechanotransduction and YAP/TAZ activation. In mouse models of breast cancer, specific loss of CCM3 in cancer-associated fibroblasts leads to exacerbated tissue remodelling and force transmission to the matrix, resulting in reciprocal YAP/TAZ activation in the neighbouring tumour cells and dissemination of metastasis to distant organs. Similarly, CCM3 regulates the differentiation of mesenchymal stromal/stem cells. In conclusion, CCM3 is a gatekeeper in focal adhesions that controls mechanotransduction and YAP/TAZ signalling.